Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma

被引:0
|
作者
Mi Jeong Heo
Jessica Yun
Sang Geon Kim
机构
[1] Seoul National University,College of Pharmacy and Research Institute of Pharmaceutical Sciences
来源
Archives of Pharmacal Research | 2019年 / 42卷
关键词
Hepatocellular carcinoma; microRNA; Long non-coding RNA; Non-coding RNA;
D O I
暂无
中图分类号
学科分类号
摘要
Hepatocellular carcinoma (HCC) is a tumor with poor prognosis and frequently aggressive. The development of HCC is associated with fibrosis and cirrhosis, which mainly results from nonalcoholic fatty liver disease, excessive alcohol consumption, and viral infections. Non-coding RNAs (ncRNAs) are RNAs transcribed from the genome, but are not translated into proteins. Recently, ncRNAs emerged as key contributors to tumor development and progression because of their abilities to regulate various targets and modulate cell proliferation, differentiation, apoptosis, and development. In this review, we summarize the frequently activated pathways in HCC and discuss the pathological implications of ncRNAs in the context of human liver disease progression, in particular HCC development and progression. This review aims to summarize the role of ncRNA dysregulation in the diseases and discuss the diagnostic and therapeutic potentials of ncRNAs.
引用
收藏
页码:48 / 62
页数:14
相关论文
共 50 条
  • [1] Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma
    Heo, Mi Jeong
    Yun, Jessica
    Kim, Sang Geon
    ARCHIVES OF PHARMACAL RESEARCH, 2019, 42 (01) : 48 - 62
  • [2] The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
    Hu, Xinyao
    Zhu, Hua
    Shen, Yang
    Zhang, Xiaoyu
    He, Xiaoqin
    Xu, Ximing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma
    Manna, Debashri
    Sarkar, Devanand
    CANCERS, 2020, 12 (05)
  • [4] Non-Coding RNAs in Hepatocellular Carcinoma
    Korsch, Mascha
    Margetts, Alexander
    Wahlestedt, Claes
    Lohse, Ines
    LIVERS, 2022, 2 (03): : 185 - 213
  • [5] The Role of Non-Coding RNAs in Liver Disease, Injury, and Regeneration
    Rowe, Melissa M. M.
    Kaestner, Klaus H. H.
    CELLS, 2023, 12 (03)
  • [6] Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression
    Ahangar Davoodi, Nasrin
    Najafi, Sajad
    Naderi Ghale-Noie, Zari
    Piranviseh, Ashkan
    Mollazadeh, Samaneh
    Ahmadi Asouri, Sahar
    Asemi, Zatollah
    Morshedi, Mohammadamin
    Tamehri Zadeh, Seyed Saeed
    Hamblin, Michael R.
    Sheida, Amirhossein
    Mirzaei, Hamed
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [7] The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action
    Shi, Xuan
    Zhu, Hai-Rong
    Liu, Tao-Tao
    Shen, Xi-Zhong
    Zhu, Ji-Min
    CANCER LETTERS, 2017, 400 : 175 - 182
  • [8] Long non-coding RNAs and hepatocellular carcinoma (Review)
    Yu, Fu-Jun
    Zheng, Jian-Jian
    Dong, Pei-Hong
    Fan, Xiao-Ming
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (01) : 13 - 17
  • [9] Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets
    Hashemi, Mehrdad
    Mirzaei, Sepideh
    Zandieh, Mohammad Arad
    Rezaei, Sahar
    Kakavand, Amirabbas
    Dehghanpour, Amir
    Esmaeili, Negin
    Ghahremanzade, Azin
    Saebfar, Hamidreza
    Heidari, Hajar
    Salimimoghadam, Shokooh
    Taheriazam, Afshin
    Entezari, Maliheh
    Seok, Kwang
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2023, 177 : 207 - 228
  • [10] Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma
    Zhang, Qian
    Li, Hanlin
    Liu, Yang
    Li, Jian
    Wu, Chunling
    Tang, Hua
    CURRENT ONCOLOGY, 2022, 29 (08) : 5383 - 5406